title: Kasabach-Merritt syndrome in a Jehovah's Witness infant.
authors.forename: U
authors.initials: U
authors.lastname: Kohdera
authors.forename: M
authors.initials: M
authors.lastname: Nishimura
authors.forename: H
authors.initials: H
authors.lastname: Higashino
authors.forename: T
authors.initials: T
authors.lastname: Murata
authors.forename: Y
authors.initials: Y
authors.lastname: Kobayashi
mesh_terms: D018931:Antineoplastic Agents, Hormonal / Q000627:therapeutic use; D001803:Blood Transfusion / Q000523:psychology; D002835:Christianity; D006391:Hemangioma / Q000188:drug therapy / Q000532:radiotherapy / Q000628:therapy*; D006801:Humans; D007231:Infant, Newborn; D008297:Male; D008602:Mental Healing; D008775:Methylprednisolone / Q000008:administration & dosage; D011239:Prednisolone / Q000008:administration & dosage; D012067:Religion; D012068:Religion and Medicine; D012878:Skin Neoplasms / Q000188:drug therapy / Q000532:radiotherapy / Q000628:therapy*; D013577:Syndrome; D013921:Thrombocytopenia / Q000628:therapy
chemical_list: D018931:Antineoplastic Agents, Hormonal; D011239:Prednisolone; D008775:Methylprednisolone